Sign up to save your podcasts
Or
Share The probability that the pandemic will be with us for the longer term has increased significantly
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The probability that the pandemic will be with us for the longer term has increased significantly
New strategy emphasis for Dr. Hess clients group in 2022.
Dr Robert Hess considers that the likelihood of a major vaccine campaign bringing the pandemic to an end this summer is diminishing. With this long-term scenario in prospect, we at the Salvagene Group have had a strategic rethink, not least because we have been allocating so much of our resources to SARS-CoV-2 research over the past twelve months. We now intend to significantly expand capacity in our core expertise, namely cancer prevention, to avoid a situation where this priority is repeatedly pushed to one side. We have to work on the assumption that the SARS-CoV-2 virus will keep us occupied for a long time to come. To meet the challenge, we will be reorganizing and significantly expanding our research capacities.
View all episodes
By Dr Robert HessNew strategy emphasis for Dr. Hess clients group in 2022.
Dr Robert Hess considers that the likelihood of a major vaccine campaign bringing the pandemic to an end this summer is diminishing. With this long-term scenario in prospect, we at the Salvagene Group have had a strategic rethink, not least because we have been allocating so much of our resources to SARS-CoV-2 research over the past twelve months. We now intend to significantly expand capacity in our core expertise, namely cancer prevention, to avoid a situation where this priority is repeatedly pushed to one side. We have to work on the assumption that the SARS-CoV-2 virus will keep us occupied for a long time to come. To meet the challenge, we will be reorganizing and significantly expanding our research capacities.